Skip to content
Nonprofiteer
← SOCIETY FOR VASCULAR SURGERY

Form 990 for tax year 2023

Filed by SOCIETY FOR VASCULAR SURGERY.

Totals

Total revenue
$14,766,161
Total expenses
$14,764,215
Contributions and grants received
$2,042,947
Grants paid
$60,163
Program service revenue
$11,664,061
Investment income
$716,224
Other revenue
$342,929
Total assets, end of year
$27,787,589
Total liabilities, end of year
$9,574,432
Net assets or fund balances, end of year
$18,213,157
Program services expenses (Part IX)
not reported
Management and general expenses
not reported
Fundraising expenses
not reported
Program service expenses (Part III)
not reported

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1e · Government grants (contributions)

    $636,487

  • 1f · All other contributions, gifts and grants

    $1,406,460

  • 2a · Program service revenue: QUALITY PRACTICE

    total $3,275,141 · related or exempt $3,275,141

  • 2b · Program service revenue: ANNUAL MEETING

    total $2,402,337 · related or exempt $2,402,337

  • 2c · Program service revenue: PUBLICATIONS

    total $2,207,931 · related or exempt $2,207,931

  • 2d · Program service revenue: MEMBERSHIP

    total $1,880,615 · related or exempt $1,880,615

  • 2e · Program service revenue: RESEARCH

    total $1,422,967 · related or exempt $1,422,967

  • 2f · All other program service revenue

    total $475,070 · related or exempt $475,070

  • 3 · Investment income

    total $505,414 · excluded $505,414

  • 5 · Royalties

    total $316,323 · unrelated business $259,923 · excluded $56,400

  • 7a · Gross sales of assets other than inventory

    securities $4,033,744

  • 7b · Less cost or other basis and sales expenses

    securities $3,822,934

  • 7c · Gain or loss

    securities $210,810

  • 7d · Net gain or loss

    total $210,810 · excluded $210,810

  • 11a · Other revenue: OTHER REVENUES

    total $16,461 · excluded $16,461

  • 11b · Other revenue: MAILING LIST RENTAL

    total $10,145 · excluded $10,145

  • 11e · Other revenue, total

    $26,606

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $8,000

  • 2 · Grants to domestic individuals

    total $52,163

  • 5 · Compensation of officers, directors and key employees

    total $696,105

  • 7 · Other salaries and wages

    total $4,711,890

  • 8 · Pension plan contributions

    total $170,753

  • 9 · Other employee benefits

    total $615,620

  • 10 · Payroll taxes

    total $415,578

  • 11b · Fees: legal

    total $36,601

  • 11c · Fees: accounting

    total $131,632

  • 11d · Fees: lobbying

    total $65,323

  • 11f · Fees: investment management

    total $82,262

  • 11g · Fees: other

    total $761,704

  • 12 · Advertising and promotion

    total $43,114

  • 13 · Office expenses

    total $235,509

  • 14 · Information technology

    total $852,705

  • 16 · Occupancy

    total $433,833

  • 17 · Travel

    total $382,792

  • 19 · Conferences, conventions and meetings

    total $1,645,884

  • 22 · Depreciation, depletion and amortization

    total $987,194

  • 23 · Insurance

    total $109,880

  • 24a · Other expenses: MANAGEMENT SERVICES

    total $831,946

  • 24b · Other expenses: HONORARIA

    total $568,042

  • 24c · Other expenses: BOOKS, DUES, FEES AND S

    total $253,713

  • 24e · All other expenses

    total $671,972

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $4,044,763 · end of year $3,323,754

  • 2 · Savings and temporary cash investments

    beginning of year $8,870,237 · end of year $9,323,019

  • 3 · Pledges and grants receivable

    beginning of year $120,340 · end of year $190,000

  • 4 · Accounts receivable

    beginning of year $367,256 · end of year $1,609,886

  • 9 · Prepaid expenses and deferred charges

    beginning of year $615,912 · end of year $549,985

  • 10a · Land, buildings and equipment: cost or other basis

    $3,407,099

  • 10b · Land, buildings and equipment: accumulated depreciation

    $2,190,784

  • 10c · Land, buildings and equipment, net

    beginning of year $1,310,295 · end of year $1,216,315

  • 11 · Investments: publicly traded securities

    beginning of year $7,089,629 · end of year $8,067,808

  • 14 · Intangible assets

    beginning of year $1,663,394 · end of year $1,394,750

  • 15 · Other assets

    beginning of year $2,624,387 · end of year $2,112,072

  • 17 · Accounts payable and accrued expenses

    beginning of year $1,250,316 · end of year $1,554,177

  • 19 · Deferred revenue

    beginning of year $5,255,080 · end of year $5,614,620

  • 25 · Other liabilities

    beginning of year $2,763,898 · end of year $2,405,635

  • 27 · Net assets without donor restrictions

    beginning of year $16,949,481 · end of year $17,737,818

  • 28 · Net assets with donor restrictions

    beginning of year $487,438 · end of year $475,339

Mission and programs · 2023

Mission

TO IMPROVE THE PREVENTION, DIAGNOSIS, AND MANAGEMENT OF PATIENTS WITHVASCULAR DISEASE BY PROMOTING CLINICAL AND BASIC RESEARCH; PROVIDINGCONTINUING EDUCATION; DEVELOPING POST-GRADUATE TRAINING; ADVOCATING ONBEHALF OF MEMBERS; PROMOTING THE DEVELOPMENT AND IMPLEMENTATION OF NEWTECHNOLOGY; PROMOTING AND FACILITATING THE DISSEMINATION OF KNOWLEDGEAND INFORMATION TO PRACTITIONERS, PATIENTS, AND THE PUBLIC;STANDARDIZING NOMENCLATURE AND REPORTING OF VASCULAR CONDITIONS;DEVELOPING PRACTICE STATEMENTS AND GUIDELINES; AND ADDRESSING RELATEDSOCIAL, ECONOMIC, ETHICAL, AND LEGAL ISSUES.

Activities or mission (Part I)

TO PROMOTE VASCULAR HEALTH THROUGH ADVANCING SCIENCE & PRACTICE OF VASCULAR DISEASE MANAGEMENT.

  • EDUCATION - SVS HOSTS AN ANNUAL MEETING AND TRADE SHOW TO PROMOTE THE STUDY AND RESEARCH OF VASCULAR DISEASES, DEFINE THE ROLE OF VASCULAR SURGERY, AND STANDARDIZE THE METHODS OF STUDY. IN ADDITION, SVS OFFERS EDUCATIONAL COURSES AND PROGRAMS TO PROMOTE THE STUDY OF VASCULAR DISEASES, EXPAND KNOWLEDGE OF SUCH DISEASES, AND ENCOURAGE GROWTH IN THE FIELD.

  • QUALITY PRACTICE - SOUGHT IMPROVEMENT OF PATIENT SAFETY AND QUALITY OF HEALTH CARE DELIVERY BY PROVIDING WEB-BASED COLLECTION, AGGREGATION, AND ANALYSIS OF CLINICAL DATA.

  • PUBLICATIONS - THE JOURNAL OF VASCULAR SURGERY IS DEDICATED TO THE SCIENCE AND ART OF VASCULAR SURGERY AND AIMS TO BE THE PREMIER INTERNATIONAL JOURNAL OF MEDICAL ENDOVASCULAR AND SURGICAL CARE OF VASCULAR DISEASES. THE GOAL OF THE JOURNAL IS TO IMPROVE THE MANAGEMENT OF PATIENTS WITH VASCULAR DISEASES BY PUBLISHING RELEVANT PAPERS THAT REPORT MEDICAL, SURGICAL, AND ENDOVASCULAR ADVANCES, TEST NEW HYPOTHESES, AND ADDRESS CURRENT CONTROVERSIES.

  • RESEARCH - ENCOURAGE THE INTEREST AND DEVELOPMENT OF INVESTIGATORS BY PROVIDING A FORUM FOR COLLABORATION AND DISSEMINATION OF ADVANCEMENTS IN OUTCOMES, COMPARATIVE EFFECTIVENESS, CLINICAL, TRANSLATIONAL, AND BASIC SCIENCE RESEARCH.

As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Michael C Dalsing MD

    IMMEDIATE PAST PRESIDENT

    Total calculated
    $0
    Hours/week
    2 + 2 related

  • Bernadette Aulivola MD

    MEMBER

    Total calculated
    $0
    Hours/week
    2 + 0.5 related

  • Joseph L Mills MD

    PRESIDENT

    Total calculated
    $0
    Hours/week
    3 + 0.5 related

  • Matthew J Eagleton MD

    PRESIDENT-ELECT

    Total calculated
    $0
    Hours/week
    3 + 0.5 related

  • William P Shutze MD

    SECRETARY

    Total calculated
    $0
    Hours/week
    2

  • Keith D Calligaro MD

    VICE PRESIDENT

    Total calculated
    $0
    Hours/week
    2

  • Kwame S Amankwah MD

    LIAISON

    Total calculated
    $0
    Hours/week
    2

  • Kellie R Brown MD

    LIAISON

    Total calculated
    $0
    Hours/week
    2

  • Andres Schanzer MD

    CHAIR

    Total calculated
    $0
    Hours/week
    2

  • Robert G Molnar MD

    CHAIR

    Total calculated
    $0
    Hours/week
    2

  • Audra A Duncan MD

    LIAISON

    Total calculated
    $0
    Hours/week
    2

  • Thomas L Forbes MD

    TREASURER

    Total calculated
    $0
    Hours/week
    2 + 0.5 related

  • Kenneth M Slaw PhD

    EXECUTIVE DIRECTOR

    Total calculated
    $444,035
    From this org
    $401,450
    From related orgs
    $0
    Other
    $42,585
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $370,705
    Bonus
    $30,745
    Other
    $0
    Deferred
    $13,200
    Nontaxable benefits
    $29,385
    Filer's total
    $444,035

  • Jim Wadzinski

    DEPUTY EXECUTIVE DIRECTOR

    Total calculated
    $252,070
    From this org
    $238,371
    From related orgs
    $0
    Other
    $13,699
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $234,803
    Bonus
    $3,568
    Other
    $0
    Deferred
    $0
    Nontaxable benefits
    $13,699
    Filer's total
    $252,070

  • Katherine Mocarski

    DIRECTOR OF FINANCE

    Total calculated
    $155,877
    From this org
    $137,187
    From related orgs
    $0
    Other
    $18,690
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $135,104
    Bonus
    $2,083
    Other
    $0
    Deferred
    $5,595
    Nontaxable benefits
    $13,095
    Filer's total
    $155,877

  • Sarah Murphy

    DIRECTOR OF RESEARCH

    Total calculated
    $197,098
    From this org
    $169,404
    From related orgs
    $0
    Other
    $27,694
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $166,818
    Bonus
    $2,586
    Other
    $0
    Deferred
    $6,944
    Nontaxable benefits
    $20,750
    Filer's total
    $197,098

  • Rupa Brosseau

    DEPUTY EXECUTIVE DIRECTOR

    Total calculated
    $173,526
    From this org
    $165,600
    From related orgs
    $0
    Other
    $7,926
    Hours/week
    5 + 35 related

    Schedule J breakdown matched by us

    Base
    $163,138
    Bonus
    $2,462
    Other
    $0
    Deferred
    $6,017
    Nontaxable benefits
    $1,909
    Filer's total
    $173,526

  • Kevin Onorato

    IT DIRECTOR

    Total calculated
    $179,580
    From this org
    $159,705
    From related orgs
    $0
    Other
    $19,875
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $157,272
    Bonus
    $2,433
    Other
    $0
    Deferred
    $6,535
    Nontaxable benefits
    $13,340
    Filer's total
    $179,580

  • Megan Marcinko

    SENIOR DIRECTOR OF ADVOCACY

    Total calculated
    $205,085
    From this org
    $195,152
    From related orgs
    $0
    Other
    $9,933
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $192,218
    Bonus
    $2,934
    Other
    $0
    Deferred
    $7,897
    Nontaxable benefits
    $2,036
    Filer's total
    $205,085

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Compensation committee
  • 3 · Written employment contract
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

  • SOCIETY FOR VASCULAR SURGERY FOUNDATION

    501(C)(3) · SUPPORT CAREER DEVELOPMENT FOR VASCULAR SURGEON RESEARCHERS. · IL

    Directly controlled by SOCIETY FOR VASCULAR SURGERY

  • SOCIETY FOR VASCULAR SURGERY PAC FUND

    527 · SUPPORT U.S. CONGRESSIONAL CANDIDATES WHO SHARE COMMON INTERESTS. · IL

    Directly controlled by SOCIETY FOR VASCULAR SURGERY

Taxable family on this return

Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.

Disregarded entities

Part I: entities that legally are the filer and file no return of their own.

  • SVS PATIENT SAFETY ORGANIZATION

    COLLECT AND ANALYZE DATA IN AN EFFORT TO IMPROVE PATIENT CARE. · IL · income $5,085,357 · assets $10,782,099

    Directly controlled by SOCIETY FOR VASCULAR SURGERY

Provenance

Return type
form_990
Tax year
2023
Filed
13 February 2025
IRS schema version
2023v6.0
Source object
202540459349300139

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.